Projects per year
Personal profile
Biography
Mark Cooper AO is Professor of Diabetes and head of the Department of Diabetes within the School of Translational Medicine. His research and clinical interests are in diabetes and its complications, including kidney disease, heart disease and blindness.
Biography
Links:
- Department of Diabetes: www.med.monash.edu.au/cecs/diabetes/
- Professor Mark Cooper: www.med.monash.edu.au/cecs/diabetes/staff/cooper-mark.html
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Diabetes
- Diabetic Complications
- kidney disease
- heart disease
- blindness
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Splice switching oligonucleotides for the treatment of chronic kidney disease
Thomas, M., Wilton, S., Wraight, C., Pickering, R., Cooper, M., Coughlan, M., Tesch, G., Kitching, R. & Jupp, B.
1/01/23 → 31/12/25
Project: Research
-
Predicting Renal, Ophthalmic and Heart Events in the Aboriginal Community: The PROPHECY Diabetes Multi-Omics Cohort Study
Brown, A., Zimmet, P., Cooper, M., Shaw, J., El-Osta, S., Willerslev, E., Maple-Brown, L. J., James, D. E., Nicholls, S. & Craig, J. E.
1/01/22 → 30/06/25
Project: Research
-
New strategy to safely and effectively reduce diabetic kidney disease
Chai, Z., Chalmers, D. & Cooper, M.
1/01/22 → 31/12/25
Project: Research
-
The Meydan Family Foundation Diabetes Complications Research Hub
Cooper, M., Jane, S. & Mitchell, C.
31/12/16 → 31/12/25
Project: Research
-
Human pancreatic ductal cell-driven beta-cell regeneration
El-Osta, S., Cooper, M., Al-Hasani, K., Loudovaris, T. & Khurana, I.
1/02/22 → 31/01/23
Project: Research
-
Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in Diabetes
Jandeleit-Dahm, K. A. M., Kankanamalage, H. R., Dai, A., Meister, J., Lopez-Trevino, S., Cooper, M. E., Touyz, R. M., Kennedy, C. R. J. & Jha, J. C., Apr 2024, In: Antioxidants. 13, 4, 18 p., 396.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
Sourris, K. C., Ding, Y., Maxwell, S. S., Al-Sharea, A., Kantharidis, P., Mohan, M., Rosado, C., Penfold, S., Haase, C. G., Xu, Y., Forbes, J. M., Crawford, S. A., Ramm, G., Harcourt, B. E., Jandeleit-Dahm, K. A. M., Advani, A., Murphy, A. J., Timmermann, D. B., Karihaloo, A., Knudsen, L. B., & 4 others, Jan 2024, In: Kidney International. 105, 1, p. 132-149 18 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access34 Citations (Scopus) -
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin A Secondary Analysis of Randomized Clinical Trials
Marx, N., Kolkailah, A. A., Rosenstock, J., Johansen, O. E., Cooper, M. E., Alexander, J. H., Toto, R. D., Wanner, C., Espeland, M. A., Mattheus, M., Schnaidt, S., Perkovic, V., Gollop, N. D. & McGuire, D. K., 2024, In: JAMA Cardiology. 9, 2, p. 134-143 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
Novel pharmacological interventions for diabetic kidney disease
Tan, S. K., Pinzon-Cortes, J. A. & Cooper, M. E., 1 Jan 2024, In: Current Opinion in Nephrology and Hypertension. 33, 1, p. 13-25 13 p.Research output: Contribution to journal › Review Article › Research › peer-review
5 Citations (Scopus) -
The GLP-1 receptor agonist revolution comes to nephrology
Thomas, M. C. & Cooper, M. E., Oct 2024, In: Nature Reviews Nephrology. 20, 10, p. 637–638 2 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Activities
- 1 Patents
-
Baker Heart and Diabetes Institute (External organisation)
Zhong-Lin Chai (Inventor) & Mark Cooper (Inventor)
29 Jul 2010Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent
Press/Media
-
Ten News Melbourne interview- New Founds Benefits of Ozempic for Kidney & Heart Disease
Melinda Coughlan & Mark Cooper
12/12/23
1 Media contribution
Press/Media: Profile/Interview
-
7NEWS interview- Surprise health benefits linked to weight-loss drug
Melinda Coughlan & Mark Cooper
12/12/23
1 Media contribution
Press/Media: Profile/Interview